289 related articles for article (PubMed ID: 24627226)
1. Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist.
Kazemi-Bajestani SM; Becher H; Fassbender K; Chu Q; Baracos VE
J Cachexia Sarcopenia Muscle; 2014 Jun; 5(2):95-104. PubMed ID: 24627226
[TBL] [Abstract][Full Text] [Related]
2. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of peripheral muscle wasting in cardiac cachexia.
Filippatos GS; Anker SD; Kremastinos DT
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):249-54. PubMed ID: 15809526
[TBL] [Abstract][Full Text] [Related]
4. The impact of cachexia on cardiorespiratory reflex control in chronic heart failure.
Ponikowski P; Piepoli M; Chua TP; Banasiak W; Francis D; Anker SD; Coats AJ
Eur Heart J; 1999 Nov; 20(22):1667-75. PubMed ID: 10543930
[TBL] [Abstract][Full Text] [Related]
5. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
Anker SD; Coats AJ
Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500
[TBL] [Abstract][Full Text] [Related]
6. Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity (Review).
Belloum Y; Rannou-Bekono F; Favier FB
Oncol Rep; 2017 May; 37(5):2543-2552. PubMed ID: 28393216
[TBL] [Abstract][Full Text] [Related]
7. Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
Springer J; Tschirner A; Haghikia A; von Haehling S; Lal H; Grzesiak A; Kaschina E; Palus S; Pötsch M; von Websky K; Hocher B; Latouche C; Jaisser F; Morawietz L; Coats AJ; Beadle J; Argiles JM; Thum T; Földes G; Doehner W; Hilfiker-Kleiner D; Force T; Anker SD
Eur Heart J; 2014 Apr; 35(14):932-41. PubMed ID: 23990596
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Remodeling in Cancer-Induced Cachexia: Functional, Structural, and Metabolic Contributors.
Wiggs MP; Beaudry AG; Law ML
Cells; 2022 Jun; 11(12):. PubMed ID: 35741060
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Complications: The Understudied Aspect of Cancer Cachexia.
Bora V; Patel B
Cardiovasc Toxicol; 2022 Mar; 22(3):254-267. PubMed ID: 35171467
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis and treatment of cardiac atrophy in cancer cachexia.
Murphy KT
Am J Physiol Heart Circ Physiol; 2016 Feb; 310(4):H466-77. PubMed ID: 26718971
[TBL] [Abstract][Full Text] [Related]
11. Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia.
Rausch V; Sala V; Penna F; Porporato PE; Ghigo A
Oncogenesis; 2021 Jan; 10(1):1. PubMed ID: 33419963
[TBL] [Abstract][Full Text] [Related]
12. The importance of biological sex in cardiac cachexia.
Holder ER; Alibhai FJ; Caudle SL; McDermott JC; Tobin SW
Am J Physiol Heart Circ Physiol; 2022 Oct; 323(4):H609-H627. PubMed ID: 35960634
[TBL] [Abstract][Full Text] [Related]
13. How progressive cancer endangers the heart: an intriguing and underestimated problem.
Ausoni S; Calamelli S; Saccà S; Azzarello G
Cancer Metastasis Rev; 2020 Jun; 39(2):535-552. PubMed ID: 32152913
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
Saitoh M; Ishida J; Doehner W; von Haehling S; Anker MS; Coats AJS; Anker SD; Springer J
Int J Cardiol; 2017 Jul; 238():5-11. PubMed ID: 28427849
[TBL] [Abstract][Full Text] [Related]
15. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure.
Heineke J; Auger-Messier M; Xu J; Sargent M; York A; Welle S; Molkentin JD
Circulation; 2010 Jan; 121(3):419-25. PubMed ID: 20065166
[TBL] [Abstract][Full Text] [Related]
17. The pathophysiology of cancer-mediated cardiac cachexia and novel treatment strategies: A narrative review.
Tichy L; Parry TL
Cancer Med; 2023 Sep; 12(17):17706-17717. PubMed ID: 37654192
[TBL] [Abstract][Full Text] [Related]
18. Muscle wasting in cardiac cachexia.
Strassburg S; Springer J; Anker SD
Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
[TBL] [Abstract][Full Text] [Related]
19. Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle.
Hulmi JJ; Nissinen TA; Räsänen M; Degerman J; Lautaoja JH; Hemanthakumar KA; Backman JT; Ritvos O; Silvennoinen M; Kivelä R
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):417-432. PubMed ID: 29230965
[TBL] [Abstract][Full Text] [Related]
20. Impact of Cancer Cachexia on Cardiac and Skeletal Muscle: Role of Exercise Training.
Bordignon C; Dos Santos BS; Rosa DD
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
